Comparison of efficacy and toxicity of FC and FCR regimens in primary B-cell chronic lymphocytic leukemia: a retrospective study
Preclinical studies showed synergic anti-tumor activity of Rituximab and Fludarabin. Comparison of efficacy of FC with FCR regimens administered in first line therapy and their influence on disease-free and overall survival in patients with B-cell lymphocytic leukemia were the main goals of this ret...
Main Authors: | Ye. А. Stadnik, Ye. А. Nikitin, B. V. Biderman, G. N. Salogub, Yu. Yu. Lorie, N. N. Tsyba, Yu. A. Alexeeva, V. A. Doronin, V. N. Mashuk, R. I. Vabishevich, A. L. Melikyan, T. I. Kolosheinova, L. Yu. Kolosova, A. B. Sudarikov, L. G. Kovaleva, A. Yu. Zaritsky |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2022-11-01
|
Series: | Онкогематология |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/679 |
Similar Items
-
Modern therapy and prognostic factors at chronic lymphoid leucosis. Review of literature and own datas
by: Ye. A. Stadnik, et al.
Published: (2008-12-01) -
FcRγ promotes T cell apoptosis in Fas-deficient mice.
by: Juvet, S, et al.
Published: (2013) -
The Diverse Functions of the Ubiquitous Fcγ Receptors and Their Unique Constituent, FcRγ Subunit
by: Thamer A. Hamdan, et al.
Published: (2020-02-01) -
EVALUATION OF FCR THERAPY EFFICACY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA BASED ON IMMUNOGENETIC CRITERIA
by: E. L. Nazarova, et al.
Published: (2018-06-01) -
Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7
by: Humphris, G, et al.
Published: (2018)